Mineral and bone disorder is a common complication found in chronic kidney disease patients. If left untreated, the abnormalities of mineral and bone metabolism may lead to morbidity and mortality. Well-controlled levels of phosphate and parathyroid hormone by applying phosphate binders, vitamin D, and/or calcimimetics in combination with non-pharmacotherapy are key elements to prevent this complication. This article provides review of the literature of management of mineral and bone disorder in chronic kidney disease for medical professionals.
